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This international collaborative survey identified culture-confirmed legionellosis in 508 pa-
tients with sporadic community-acquired legionellosis. Legionella pneumophila constituted
91.5% of the isolates. Serogroup 1 was the predominant serogroup (84.2%), and serogroups
2–13 (7.4%) accounted for the remaining serogroups. The Legionella species most commonly
isolated were L. longbeachae (3.9%) and L. bozemanii (2.4%), followed by L. micdadei, L.
dumoffii, L. feeleii, L. wadsworthii, and L. anisa (2.2% combined). L. longbeachae constituted
30.4% of the community-acquired Legionella isolates in Australia and New Zealand.
Forty-two Legionella species with 64 serogroups have been
classified to date [1]. The incidence of community-acquired pneu-
monia caused by these species and serogroups remains largely
unknown because many bacterial isolates cannot be diagnosed
by current microbiologic tests. Direct fluorescent antibody (DFA)
stains and serologic tests are available only for a limited number
of species, whereas the urinary antigen test has high sensitivity
only for Legionella pneumophila serogroup 1.
In 1984, the Centers for Disease Control and Prevention
(CDC) published a retrospective survey of Legionella serogroups
and species in the United States, on the basis of 335 specimens
submitted to the CDC or 11 state health departments [2]. The
conclusion was that L. pneumophila was responsible for 80%–85%
of Legionella infections and that serogroups 1 and 6 were re-
sponsible for two-thirds of all Legionella infections. However,
there were limitations to this survey. Culture, the most sensitive
test, was not widely available, so DFA staining of respiratory
tract secretions and tissue was the diagnostic test performed.
Background information for most isolates was not available, and
clinical information concerning community versus hospital ac-
quisition and sporadic versus outbreak-related cases was not
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available [2]. Furthermore, new serogroups and species of Le-
gionella have been discovered since 1984. A contemporary as-
sessment of Legionella species and serogroups causing pneumonia
would be important, so we initiated a prospective and retro-
spective tabulation of sporadic cases of culture-confirmed Le-
gionella infection in patients with community-acquired legionel-
losis in an international multicenter survey.
Methods
Twenty hospital laboratories in North America, Europe, Aus-
tralia, and New Zealand with expertise in laboratory diagnosis of
Legionella infections were invited to participate in a survey of spo-
radic cases of community-acquired pneumonia due to Legionella
species. The 20 hospitals were identified by review of literature
reports in which cases of community-acquired legionellosis were
identified by culture methodology. Twelve hospitals accepted the
invitation.
The most common reason given for nonparticipation was that
culture results could not be classified as sporadic versus outbreak
and community-acquired versus hospital-acquired because of a lack
of clinical data. One hospital laboratory was removed at the outset
of the study because respiratory tract specimens were accepted from
other hospital laboratories, and the investigators were unable to con-
firm that all cases were sporadic rather than outbreak-related. One
hospital laboratory withdrew because of failure to enroll any cases
in the first year of the study. Government or public health agency
laboratories were not invited to participate, to rule out the possibility
that outbreak-related cases might inadvertently be included.
Thus, 10 hospital laboratories with expertise in culture of Legion-
ella species performed both prospective and retrospective surveys of
Legionella species isolated from the respiratory tracts of consecutive
patients with sporadic community-acquired pneumonia. Data were
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Table 1. Classification of respiratory tract Legionella
species and serogroups isolated from consecutive pa-
tients with community-acquired pneumonia.
Legionella species,
serogroup Species Serogroup
L. pneumophila 91.5 (465)
1 84.2 (428)
6 1.7 (9)
5 1.3 (7)
4 1.0 (5)
3 1.0 (5)
7 0.6 (3)
2 0.4 (2)
8 0.4 (2)
13 0.4 (2)
Unknowna 0.6 (3)
L. longbeachae 3.9 (20)
Unknown 2.6 (13)
1 1.2 (6)
2 0.1 (1)
L. bozemanii 2.4 (12)
Unknown 2.0 (10)
1 0.2 (1)
2 0.2 (1)
L. micdadei 0.6 (3)
L. dumoffii 0.6 (3)
L. feeleii 0.4 (2)
L. wadsworthii 0.2 (1)
L. anisa 0.2 (1)
Unknown species 0.2 (1)
Total 100 (508)
NOTE. Data are percentage (no.) of isolates.
a Serogroup unknown but not serogroup 1.
collected prospectively from 1997 through 2001 and retrospectively
from as early as 1980–1993, depending on the hospital.
The serogroups and species were confirmed by established meth-
ods, as described elsewhere [3]. In brief, colonies morphologically
consistent with Legionella species were subcultured to buffered char-
coal yeast extract agar and selective media with and without cefa-
mandole. Culture plates were incubated for 10–14 days. DFA staining
was performed to identify individual species and serogroups.
Results
In total, 508 cases of culture-confirmed community-acquired
legionellosis were identified. Isolates were from the United
States (72.2%), Italy (12.6%), Switzerland (6.1%), Australia
(4.7%), and New Zealand (4.3%) (table 1). L. pneumophila was
the most frequently isolated species (91.5% of isolates). L. long-
beachae comprised 3.9% of the organisms; however, 14 of those
20 isolates originated in Australia and New Zealand.
Discussion
Hospital-acquired outbreaks of legionnaires disease have in-
volved serogroups other than L. pneumophila serogroup 1 (es-
pecially serogroups 4 and 6) and Legionella species other than
L. pneumophila, especially L. micdadei, L. dumoffii, and L. boz-
emanii [4]. However, this survey documents that community-
acquired legionnaires disease is dominated by L. pneumophila
serogroup 1. Table 1 shows that 84.2% of all isolates were L.
pneumophila serogroup 1 and that the remaining L. pneumophila
serogroups accounted for only 7.4% of the isolates. Species
other than L. pneumophila were rare: L. longbeachae (3.9%) and
L. bozemanii (2.4%) accounted for most of the nonpneumophila
cases. L. micdadei, L. feeleii, L. dumoffii, L. wadsworthii, and
L. anisa combined accounted for 2.2% of the remaining cases.
This distribution of species and serogroups has implications
for the development of molecular tests that will have the widest
utility. For example, the Binax urinary antigen appears to be
clinically useful for community-acquired pneumonia outside
Australia and New Zealand, since L. pneumophila serogroup 1
accounted for 88.2% (407/461) of American and European Le-
gionella isolates. In contrast, for Australia and New Zealand,
L. pneumophila serogroup 1 accounted for only 45.7% of cases
of community-acquired legionellosis, and L. longbeachae ac-
counted for 30.4% of cases.
A major limitation of this study is the relatively small number
of laboratories in only a few countries, so the results cannot
be considered representative. We were surprised by how few
reference laboratories for Legionella compiled clinical data on
culture-confirmed cases of legionellosis. At the present time, it
is not possible to perform a truly representative international
survey of culture-confirmed cases of community-acquired le-
gionellosis, since most public health and government labora-
tories fail to collect clinical data on consecutive cases or fail to
differentiate between outbreak and sporadic cases of legion-
naires disease. A second limitation is that the culture meth-
odology may favor growth of L. pneumophila over that of other
species [5]; however, 8 of the 10 hospital laboratories isolated
7 species other than L. pneumophila. Nevertheless, this study
is now the largest survey of pathogenic Legionella serogroups
and species ever reported and is the only study that used the
undisputed reference standard of culture confirmation.
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